Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKesson
Baxter
Harvard Business School
AstraZeneca

Last Updated: June 4, 2023

Quagen Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?

QUAGEN has eighteen approved drugs.



Summary for Quagen
US Patents:0
Tradenames:13
Ingredients:13
NDAs:18

Drugs and US Patents for Quagen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quagen CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 211240-001 Feb 17, 2022 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Quagen FLUOCINOLONE ACETONIDE fluocinolone acetonide OIL;TOPICAL 212761-001 Apr 2, 2021 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Quagen FLUOCINOLONE ACETONIDE fluocinolone acetonide OIL/DROPS;OTIC 212762-001 Apr 2, 2021 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Quagen PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE codeine phosphate; promethazine hydrochloride SYRUP;ORAL 214238-001 Oct 8, 2020 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
Quagen OXYCODONE HYDROCHLORIDE oxycodone hydrochloride SOLUTION;ORAL 213761-001 Jun 2, 2021 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
Quagen TRIAMCINOLONE ACETONIDE triamcinolone acetonide PASTE;DENTAL 214582-001 Dec 9, 2022 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Colorcon
Boehringer Ingelheim
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.